NASDAQ:RAIN

Rain Therapeutics Stock Forecast

etoro logo Buy RAIN
*Your capital is at risk
$5.41
-1.13 (-17.28%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of RAIN
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

High volatility in Rain Therapeutics Inc. stock price on Monday which ended trading at $5.41
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Nov 13, 2025 Loss -2.87%

The Rain Therapeutics Inc. stock price fell by -17.28% on the last day (Monday, 17th Nov 2025) from $6.54 to $5.41. During the last trading day the stock fluctuated 14.64% from a day low at $5.26 to a day high of $6.03. The price has fallen in 6 of the last 10 days but is still up by 1.31% over the past 2 weeks. Volume has increased on the last day by 4 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 56 thousand shares were bought and sold for approximately $300.27 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 25.22% during the next 3 months and, with a 90% probability hold a price between $5.87 and $10.04 at the end of this 3-month period.

RAIN Signals & Forecast

A sell signal was issued from a pivot top point on Thursday, September 11, 2025, and so far it has fallen -20.79%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Rain Therapeutics Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". Some positive signals were issued as well, and these may have some influence on the near short-term development. The Rain Therapeutics Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $5.46. On a fall, the stock will find some support from the long-term average at approximately $5.35. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal.

Support, Risk & Stop-loss for Rain Therapeutics Inc. stock

Rain Therapeutics Inc. finds support from accumulated volume at $5.25 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.770 between high and low, or 14.64%. For the last week, the stock has had daily average volatility of 21.72%.

Our recommended stop-loss: $5.13 (-5.14%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 47 days ago.)

Trading Expectations (RAIN) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Rain Therapeutics Inc. to open at $5.57, and during the day (based on 14 day Average True Range), to move between $5.03 and $5.79, which gives a possible trading interval of +/-$0.752 (+/-14.94%) up or down from last closing price. If Rain Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 14.94% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $5.44 (0.55%) than the support at $5.25 (2.96%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Rain Therapeutics Inc. stock A Buy?

Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.

Current score: 3.017 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $5.57 ( 2.90%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

RAIN Performance

Trading levels for RAIN

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 6.34 17.13%
R2 6.04 11.69%
R1 5.86 8.33%
Price 5.41
S1 5.27 -2.54%
S2 5.09 -5.90%
S3 4.80 -11.34%

Accumulated Volume Support & Resistance Levels

Level Price
R3 6.11 12.94%
R2 6.00 10.91%
R1 5.44 0.555%
Price 5.41
S1 5.25 -2.96%
S2 5.16 -4.62%
S3 4.38 -19.04%

FAQ

What is the symbol for Rain Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Rain Therapeutics Inc. is RAIN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Rain Therapeutics Inc. Stock?
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.

How to buy Rain Therapeutics Inc. Stock?
Rain Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rain Therapeutics Inc. Stock.

What's the current price of Rain Therapeutics Inc. Stock?
As of the end of day on the Nov 17, 2025, the price of an Rain Therapeutics Inc. (RAIN) share was $5.41.

What is the 52-week high and low for Rain Therapeutics Inc. Stock?
The 52-week high for Rain Therapeutics Inc. Stock is $10.84 and the 52-week low is $1.75.

What is the market capitalization of Rain Therapeutics Inc. Stock?
As of the Nov 17, 2025, the market capitalization of Rain Therapeutics Inc. is 40.731M.
Click to get the best stock tips daily for free!
ABOUT RAIN THERAPEUTICS INC.
Rain Therapeutics
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in Phase 3 clinical trial for liposarcoma, Phase II clinical trial for solid tumors, and Phase II clinica...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE